FDA Inspection
Novacyl Wuxi Pharmaceutical Co., Ltd.Novacyl Wuxi Pharmaceutical Co., Ltd. – FDA Inspection, Sep 15, 2017
Record Details
This FDA Inspection record concerns Novacyl Wuxi Pharmaceutical Co., Ltd., with an inspection on September 15, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- September 15, 2017
- Product Type
- Human Drugs
View Company Profile
ID · 1379cff2-3803-4f69-9cda-c9212000a332
Inspection Facts
- Inspection number
- 1029764
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Novacyl Wuxi Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 14, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 18, 2013 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 21, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novacyl Wuxi Pharmaceutical Co., Ltd.
- FDA Inspection 965700 - 2016-04-14
- FDA Inspection 853505 - 2013-10-18
- FDA Inspection 735469 - 2011-04-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.